Delivery Order SPE2D021D0005-SPE2D324F199V
Award Date
8/15/24
Potential Completion Date
8/20/24
Potential Value
$16K
Federal Agency
Medical Supply Chain
Awardee
Genentech Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Defense Logistics Agency (DLA) for the supply of the drug TNKase 50 mg kits. The contract has a ceiling value of $10,739.70 and an ultimate completion date of April 11, 2025. The contract is not set aside for any special designation. Genentech is a key supplier of critical medications and pharmaceuticals to various federal agencies, including the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer. The $10,739.70 firm fixed-price contract is for the supply of 4568495914 - TNKASE 50 MG KITS, with a completion date of June 12, 2025. The contract is not associated with a set-aside designation. Genentech has established several significant federal contract vehicles, including a $4.9 billion Federal Supply Schedule...
This is a delivery order awarded to Genentech USA, Inc. by the Defense Logistics Agency (DLA) for the supply of TNKASE 50 MG KITS, a pharmaceutical product. The order has a ceiling value of $10,418.18 and a firm fixed-price contract type. The ultimate completion date for the order is October 8, 2024. Genentech USA, Inc. is a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics that holds several contract vehicles with federal agencies, including a $4.9 billion Federal Supply...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer. The $872,420.96 firm fixed-price contract is for the provision of various medical supplies and pharmaceuticals, including critical medications such as Tamiflu, Activase, TNKase, and Xofluza, as well as routine medications like clonazepam and diazepam tablets. The contract has an ultimate completion date of June 22,...
This federal contract award is for the delivery of pharmaceutical products, specifically "TNKASE 50 MG KITS," to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $21,255.95 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology company that manufactures pharmaceuticals. The contract is for the delivery of 50 mg vials of the drug Activase (alteplase), which is used to treat ischemic stroke. The award has a ceiling value of $3,256.83 and a period of performance through July 26, 2024. Genentech has multiple contract vehicles with the federal government, including a $4.9 billion Federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TNKASE 50 MG KITS. The delivery order, valued at $5,757.16, is a firm fixed-price contract with a performance period through June 18, 2024. No set-aside designation is indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
The U.S. Defense Logistics Agency (DLA) awarded a $7,985.32 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Tenecteplase Injection Kits. This delivery order was issued under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA, which supports the recurring pharmaceutical supply needs of military health facilities worldwide. The IDC, under the DLA's SPE2DB program, allows the agency...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor in the United States. The contract is for the supply of TNKASE 50 MG KITS, a medical product, with a ceiling value of $28,652.53 and a completion date of August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of TNKASE 50 MG KITS. The contract is a Firm Fixed Price award with a ceiling value of $13,745.76 and a completion date of July 22, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide...